Free Trial

LENZ Therapeutics (LENZ) Short Interest Ratio & Short Volume

LENZ Therapeutics logo
$27.93
+0.97 (+3.60%)
(As of 11/1/2024 ET)

LENZ Therapeutics Short Interest Data

LENZ Therapeutics (LENZ) has a short interest of 2.01 million shares, representing 8.96% of the float (the number of shares available for trading by the public). This marks a 3.08% increase in short interest from the previous month. The short interest ratio (days to cover) is 13.0, indicating that it would take 13.0 days of the average trading volume of 134,567 shares to cover all short positions.

Current Short Interest
2,010,000 shares
Previous Short Interest
1,950,000 shares
Change Vs. Previous Month
+3.08%
Dollar Volume Sold Short
$52.72 million
Short Interest Ratio
13.0 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
27,500,000 shares
Float Size
22,440,000 shares
Short Percent of Float
8.96%
Today's Trading Volume
116,734 shares
Average Trading Volume
134,567 shares
Today's Volume Vs. Average
87%
Short Selling LENZ Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for LENZ Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LENZ Short Interest Over Time

LENZ Days to Cover Over Time

LENZ Percentage of Float Shorted Over Time

LENZ Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/20242,010,000 shares $52.72 million +3.1%9.0%13 $26.23
9/30/20241,950,000 shares $46.29 million +1.6%8.7%13.3 $23.74
9/15/20241,920,000 shares $41.97 million -3.0%8.6%12 $21.86
8/31/20241,980,000 shares $46.31 million -5.7%9.0%11.2 $23.39
8/15/20242,100,000 shares $47.46 million +8.8%9.5%11.9 $22.60
7/31/20241,930,000 shares $47.92 million -3.5%10.6%10.3 $24.83
7/15/20242,000,000 shares $43.42 million No Change10.9%9.9 $21.71

LENZ Short Interest - Frequently Asked Questions

What is LENZ Therapeutics' current short interest?

Short interest is the volume of LENZ Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 2,010,000 shares of LENZ short. 8.96% of LENZ Therapeutics' shares are currently sold short. Learn More on LENZ Therapeutics' current short interest.

What is a good short interest ratio for LENZ Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LENZ shares currently have a short interest ratio of 13.0. Learn More on LENZ Therapeutics's short interest ratio.

What is a good short interest percentage for LENZ Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.96% of LENZ Therapeutics' floating shares are currently sold short.

Is LENZ Therapeutics' short interest increasing or decreasing?

LENZ Therapeutics saw a increase in short interest in October. As of October 15th, there was short interest totaling 2,010,000 shares, an increase of 3.1% from the previous total of 1,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is LENZ Therapeutics' float size?

LENZ Therapeutics currently has issued a total of 27,500,000 shares. Some of LENZ Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LENZ Therapeutics currently has a public float of 22,440,000 shares.

How does LENZ Therapeutics' short interest compare to its competitors?

8.96% of LENZ Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to LENZ Therapeutics: MeiraGTx Holdings plc (2.74%), Taysha Gene Therapies, Inc. (10.10%), Voyager Therapeutics, Inc. (6.33%), Zura Bio Limited (4.45%), iTeos Therapeutics, Inc. (13.60%), Lexeo Therapeutics, Inc. (9.37%), Sangamo Therapeutics, Inc. (8.75%), Fate Therapeutics, Inc. (14.10%), Jasper Therapeutics, Inc. (15.63%), Sutro Biopharma, Inc. (3.49%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short LENZ Therapeutics stock?

Short selling LENZ is an investing strategy that aims to generate trading profit from LENZ Therapeutics as its price is falling. LENZ shares are trading up $0.97 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against LENZ Therapeutics?

A short squeeze for LENZ Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LENZ, which in turn drives the price of the stock up even further.

How often is LENZ Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LENZ, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:LENZ) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners